Heterophasic polypropylene composition

Patent metadata

Field	Value
Publication number	US-11084920-B2
Application number	US-201816769510-A
Country	US
Kind code	B2
Filing date	Dec 18, 2018
Priority date	Dec 20, 2017
Publication date	Aug 10, 2021
Grant date	Aug 10, 2021

Abstract

The invention relates to a new soft heterophasic propylene copolymer with increased melting temperature, improved stiffness and optical properties, as well as the process by which the heterophasic propylene copolymer is produced. Further the present invention is directed to articles made of the inventive heterophasic propylene copolymer, particularly to blow moulded, extrusion blow moulded or injection moulded articles and their use in e.g. medical, pharmaceutical or alimentary applications.

First claim

The invention claimed is:

1. A heterophasic polypropylene composition comprising:
a. a crystalline matrix being a multimodal propylene random copolymer of ethylene and/or C4-C12 alpha-olefin(s) as further comonomers and
b. an amorphous propylene-ethylene elastomer optionally comprising of C4-C12 alpha-olefin(s) as further comonomers dispersed in said crystalline matrix (a),
wherein the heterophasic polypropylene composition is characterised by
i. a xylene cold solubles (XCS) fraction according to ISO 1652 in the range of 5.0 to 16.5 wt. %,
ii. an comonomer content of the XCS fraction (Co(XCS)) in the range of 8.0 to 16.5 wt. %,
iii. and optionally fulfilling the inequation
0.80≤ XCS/Co ( XCS )≤1.20,

wherein XCS denominates the xylene cold solubles fraction according to ISO 1652 in [wt. %] and Co(XCS) is the comonomer content of said XCS fraction in [wt. %].

2. The heterophasic polypropylene composition according to claim 1 comprising:
a. 80.0-90.0 wt. % of a crystalline matrix being a multimodal propylene random copolymer of ethylene and/or C4-C12 alpha-olefin(s) as further comonomers and
b. 10.0-20.0 wt. % of an amorphous propylene-ethylene elastomer optionally comprising of C4-C12 alpha-olefin(s) as further comonomers dispersed in said crystalline matrix (a).

3. The heterophasic propylene composition according to claim 2 , wherein the multimodal propylene random copolymer of ethylene and or alpha-olefins (a) comprises:
a1) 30.0-50.0 wt. %, based on the total weight of the heterophasic polypropylene composition, of a first polypropylene fraction being a propylene homopolymer or propylene-ethylene random copolymer,
optionally having a comonomer content in the range of 0.0-1.0 wt. %, and/or
a melt flow rate MFR2 in the range of 2.0-10.0 g/10 min, and
a2) 30.0-60.0 wt. %, based on the total weight of the heterophasic polypropylene composition, of a second polypropylene fraction being a propylene-ethylene random copolymer, and
optionally having a comonomer content in the range of above 1.0-7.0 wt. %, and/or
a melt flow rate MFR2 in the range of 0.2-2.0 g/10 min.

4. The heterophasic propylene composition according to claim 1 , wherein the heterophasic propylene composition comprises an intrinsic viscosity (IV) of the XCS fraction as determined according to DIN ISO 1628/1 in Decalin at 135° C. of less than 2.0 dl/g.

5. The heterophasic propylene composition according to claim 1 wherein,
a hexane-soluble fraction of at most 1.5 wt. % when determined according to FDA method and/or a comonomer content of 1.0-7.0 wt. %.

6. The heterophasic propylene composition according to claim 1 further comprising a 0.001-0.50 wt. % of an alpha-nucleating agent and/or having a MFR230/2.16 according to ISO1133 in the range of 0.3-3.5 g/10 min.

7. The heterophasic propylene composition according to claim 1 , having a melting point Tm of at least 145° C. and one glass transition temperature Tg in the range of (−15) to 0° C.

8. The heterophasic polypropylene composition according to claim 1 , comprising a flexural Modulus according to ISO178 of at least 900 MPa and/or Notched Impact Strength NIS determined according to ISO179/1 eA at +23° C. of 4.0-40.0 kJ/m 2 .

9. The heterophasic polypropylene composition according to claim 1 , consisting of a Haze 1 of at most 20.0% when measured according to ASTM D1003 on 1 mm injection moulded plaques.

10. A process for preparing the heterophasic polypropylene composition according to claim 1 by sequential polymerisation in the presence of a metallocene catalyst, wherein:
preparing a first polypropylene fraction being a propylene homopolymer or a propylene-ethylene random copolymer in a bulk phase reactor in a first polymerisation stage,
transferring said first polypropylene fraction to a second polymerisation stage in which a second polypropylene fraction being a propylene-ethylene random copolymer is prepared in a gas phase reactor (GPR1),
transferring the mixture comprising said first and second polypropylene fraction together to the third polymerisation stage in which the amorphous propylene ethylene elastomer is prepared in a gas phase reactor (GPR3), and
subjecting the mixture of said three polymers to a deactivation and purification step followed by compounding and pelletization.

11. The process according to claim 10 , wherein the:
MFR2 of the first polypropylene fraction produced in the first stage is in the range of 2.0 to 10.0 g/10 min,
the MFR2 of the second polypropylene fraction produced in the second stage is in the range of 0.2 to less than 2.0 g/10 min, and
the MFR2 of the amorphous propylene ethylene elastomer produced in the third stage is in the range of 8.0 to 200.0 g/10 min.

12. The process according to claim 10 , wherein:
the ethylene content of the first polypropylene fraction produced in the first stage is in the range of 0.0 to 1.0 wt. %,
the ethylene content of the second polypropylene fraction produced in the second stage is in the range of more than 1.0 to 7.0 wt. %, and
the ethylene content of the amorphous propylene ethylene elastomer produced in the third stage is in the range of 9.0 to 25.0 wt. %.

13. A heterophasic polypropylene composition produced according to claim 10 .

14. A moulded article comprising the heterophasic polypropylene composition according to claim 1 .

15. The moulded article of claim 13 , being used for alimentary, packaging, medical, healthcare, pharmaceutical or diagnostic applications.

16. The moulded article according to claim 14 , wherein the moulded article is a container, a bottle, or an ampoule.

Assignees

• Borealis Ag

Inventors

• Gahleitner Markus
• Wang Jingbo
• Bernreitner Klaus
• Leskinen Pauli
• Lilja Johanna

Classifications

• C08F2420/07

  Heteroatom-substituted Cp, i.e. Cp or analog where at least one of the substituent of the Cp or analog ring is or contains a heteroatom · CPC title

• C08F4/65912

  in combination with an organoaluminium compound · CPC title

• C08L23/14 Primary

  Copolymers of propene (C08L23/16 takes precedence) · CPC title

• C08L23/142 Primary

  at least partially crystalline copolymers of propene with other olefins · CPC title

• C08F210/06

  Propene · CPC title